A. Hürlimann

648 total citations
26 papers, 483 citations indexed

About

A. Hürlimann is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A. Hürlimann has authored 26 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Physiology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in A. Hürlimann's work include Pain Mechanisms and Treatments (5 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). A. Hürlimann is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). A. Hürlimann collaborates with scholars based in Switzerland and United States. A. Hürlimann's co-authors include W. Haefely, H. Thoenen, K.F. Gey, Carl J. Wiggers, W Haefely, K. Berneis, R. O. Studer, W. Lergier, K. Vogler and M Gerold and has published in prestigious journals such as Circulation Research, The Journal of Physiology and Annals of the New York Academy of Sciences.

In The Last Decade

A. Hürlimann

26 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hürlimann Switzerland 14 200 195 101 56 44 26 483
H. J. Sch�mann Germany 15 173 0.9× 281 1.4× 142 1.4× 61 1.1× 26 0.6× 37 591
John M. Stavorski United States 11 200 1.0× 219 1.1× 132 1.3× 53 0.9× 60 1.4× 16 593
Ronald D. Robson Switzerland 15 178 0.9× 221 1.1× 102 1.0× 143 2.6× 74 1.7× 33 575
L. Cubeddu United States 12 267 1.3× 360 1.8× 124 1.2× 57 1.0× 43 1.0× 15 587
Paul H. Volkman United States 7 170 0.8× 155 0.8× 73 0.7× 54 1.0× 23 0.5× 9 376
De Schaepdryver Af 10 162 0.8× 152 0.8× 118 1.2× 82 1.5× 37 0.8× 55 462
Herbert C. Wenger United States 10 225 1.1× 263 1.3× 130 1.3× 132 2.4× 42 1.0× 18 659
A.F. De Schaepdryver Belgium 14 265 1.3× 309 1.6× 139 1.4× 80 1.4× 26 0.6× 40 671
H Schmitt France 11 237 1.2× 235 1.2× 200 2.0× 113 2.0× 52 1.2× 21 567
P A Nasmyth United Kingdom 12 160 0.8× 219 1.1× 107 1.1× 72 1.3× 39 0.9× 29 478

Countries citing papers authored by A. Hürlimann

Since Specialization
Citations

This map shows the geographic impact of A. Hürlimann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hürlimann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hürlimann more than expected).

Fields of papers citing papers by A. Hürlimann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hürlimann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hürlimann. The network helps show where A. Hürlimann may publish in the future.

Co-authorship network of co-authors of A. Hürlimann

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hürlimann. A scholar is included among the top collaborators of A. Hürlimann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hürlimann. A. Hürlimann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thoenen, H., A. Hürlimann, & W. Haefely. (1968). Mechanism of amphetamine accumulation in the isolated perfused heart of the rat. Journal of Pharmacy and Pharmacology. 20(1). 1–11. 44 indexed citations
2.
Haeusler, G., H. Thoenen, W Haefely, & A. Hürlimann. (1968). [Antidromic activity evoked by drugs in the cardiac sympathetic nerve and its relation to noradrenaline liberation].. PubMed. 260(2). 129–30. 1 indexed citations
3.
Thoenen, H., et al.. (1968). [Antidromic activity induced by acetylcholine in the cardiac sympathetic nerve, and noradrenaline liberation under the influence of guanethidine].. PubMed. 26(3). CR352–4. 3 indexed citations
4.
Haefely, W., A. Hürlimann, & H. Thoenen. (1967). Some Pharmacological Actions of the <i>β</i>-adrenolytic Agent Ro 3-3528 (6,7-dimethyl-<i>α</i>-[(isopropylamino) methyl]-2-benzofuranmethanol Hydrochloride). Journal of Vascular Research. 4(3-4). 203–215. 4 indexed citations
5.
Haefely, W., H. Thoenen, & A. Hürlimann. (1967). [Qualitatively and quantitatively different effects of alpha-methyldopa treatment on cats according to a dosage scheme].. PubMed. 257(1). 25–6. 1 indexed citations
6.
Haefely, W, A. Hürlimann, & H. Thoenen. (1967). [Effects of nicotine, DMPP, TMA, amphetamine and KCl on the demarcation potential of the superior cervical ganglion and ganglionic transmission].. PubMed. 25(4). CR418+–CR418+. 2 indexed citations
7.
Thoenen, H., W. Haefely, Gey Kf, & A. Hürlimann. (1966). [The replacement of noradrenaline by dopamine as a postganglionic sympathetic transmitter in the inhibition of dopamine beta-hydroxylase by disulfiram].. PubMed. 68. C118–9. 2 indexed citations
8.
Haefely, W., A. Hürlimann, & H. Thoenen. (1966). THE EFFECT OF STIMULATION OF SYMPATHETIC NERVES IN THE CAT TREATED WITH RESERPINE, α‐METHYLDOPA AND α‐METHYLMETATYROSINE. British Journal of Pharmacology and Chemotherapy. 26(1). 172–185. 13 indexed citations
9.
Haefely, W., H. Thoenen, & A. Hürlimann. (1965). The effect of sympathetic nerve stimulation in cats pretreated with α-methyl-meta-tyrosine. Life Sciences. 4(8). 913–918. 5 indexed citations
10.
Thoenen, H., A. Hürlimann, & W Haefely. (1965). The Effect of Angiotensin on the Response to Postganglionic Sympathetic Stimulation of the Cat Spleen; Lack of Facilitation of Norepinephrine Liberation. Pharmacology. 13(6). 379–387. 16 indexed citations
11.
Haefely, W., A. Hürlimann, & H. Thoenen. (1965). Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat.. The Journal of Physiology. 181(1). 48–58. 47 indexed citations
12.
Thoenen, H., A. Hürlimann, & W. Haefely. (1965). A technique for repetitive long-term measurement of aortic pressure and cardiac output in the unanaesthetized dog using an implanted catheter. Cellular and Molecular Life Sciences. 21(3). 168–169. 2 indexed citations
13.
Thoenen, H., A. Hürlimann, & W. Haefely. (1965). On the mode of action of chlorpromazine on peripheral adrenergic mechanisms. International Journal of Neuropharmacology. 4(2). 79–89. 24 indexed citations
14.
Thoenen, H., W. Haefely, K.F. Gey, & A. Hürlimann. (1965). Diminished effects of sympathetic nerve stimulation in cats pretreated with disulfiram; liberation of dopamine as sympathetic transmitter. Life Sciences. 4(21). 2033–2038. 37 indexed citations
15.
Thoenen, H., A. Hürlimann, & W. Haefely. (1964). Dual site of action of phenoxybenzamine in the cat's spleen: Blockade of α-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine. Cellular and Molecular Life Sciences. 20(5). 272–273. 44 indexed citations
16.
Thoenen, H., A. Hürlimann, & W. Haefely. (1963). Removal of infused norepinephrine by the Cat's spleen; mechanism of its inhibition by phenoxybenzamine. Cellular and Molecular Life Sciences. 19(11). 601–602. 13 indexed citations
17.
Haefely, W., A. Hürlimann, & H. Thoenen. (1963). THE RESPONSES TO TYRAMINE OF THE NORMAL AND DENERVATED NICTITATING MEMBRANE OF THE CAT: ANALYSIS OF THE MECHANISMS AND SITES OF ACTION. British Journal of Pharmacology and Chemotherapy. 21(1). 27–38. 8 indexed citations
18.
Vogler, K., W. Haefely, A. Hürlimann, et al.. (1963). A NEW PURIFICATION PROCEDURE AND BIOLOGICAL PROPERTIES OF SUBSTANCE P. Annals of the New York Academy of Sciences. 104(1). 378–390. 53 indexed citations
19.
Haefely, W. & A. Hürlimann. (1962). Substance P, a highly active naturally occurring polypeptide. Cellular and Molecular Life Sciences. 18(7). 297–303. 36 indexed citations
20.
Haefely, W, H. Thoenen, & A. Hürlimann. (1962). The Effect of Intraventricular Application of Substance P Preparations of Different Purity. Pharmacology. 7(4). 245–249. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026